Table 2.
Characteristic | Group 1 (n = 50) | Group 2 (n = 60) | P value |
---|---|---|---|
Age, years |
66.8 ± 1.6 |
60.3 ± 2.1 |
0.048 |
Gender (men) |
32 ( 64.0 ) |
40 (66.7) |
0.770 |
APACHE II score |
23.3 ± 1.0 |
22.1 ± 0.9 |
0.463 |
SOFA score |
9.88 ± 0.51 |
8.12 ± 0.52 |
0.014 |
DIC score |
4.47 ± 0.28 |
4.38 ± 0.28 |
0.798 |
Shock |
32 ( 64.0) |
27 (45.0) |
0.047 |
Severe underlying disease |
29 (58.0) |
36 (60.0) |
0.832 |
Chronic cardiac insufficiency |
1 |
5 |
0.145 |
Diabetes mellitus |
8 |
5 |
0.215 |
Hepatic cirrhosis |
8 |
4 |
0.118 |
Neoplasm |
3 |
6 |
0.446 |
Immunosupression |
6 |
12 |
0.259 |
Chronic renal insufficiency |
2 |
0 |
0.118 |
Chronic pulmonary insufficiency |
1 |
3 |
0.403 |
Localization of primary infection | |||
Abdomen |
24 (48.0) |
26 (43.3) |
0.625 |
Lung |
13 (26.0) |
25 (41.7) |
0.085 |
Soft tissue |
9 (18.0) |
6 (10.0) |
0.223 |
Other |
4 (8.0) |
3 (5.0) |
0.521 |
AT III (%) |
56.6 ± 3.4 |
57.9 ± 2.9 |
0.643 |
Cr (mg/dl) |
2.28 ± 0.21 |
1.43 ± 0.16 |
< 0.001 |
BUN (mg/dl) | 41.9 ± 3.6 | 32.7 ± 3.0 | 0.018 |
Group 1: patients with a DSOF of 24 h or less (≤24 h); group 2: patients with a DSOF of more than 24 h (>24 h).